MktsMarkets

ResMed Inc.
NYSE: RMDKey statistics
RMD News
Stories mentioning RMD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,431,406 | 1,422,808 | 1,335,582 | 1,347,993 | 1,291,736 | 1,282,089 | 1,224,509 | 1,223,195 |
| Cost of Goods Sold | 540,427 | 544,084 | 514,762 | 527,926 | 525,327 | 530,814 | 507,290 | 507,667 |
| Gross Profit | 890,979 | 878,724 | 820,820 | 820,067 | 766,409 | 751,275 | 717,219 | 715,528 |
| Operating Expenses | ||||||||
| Research & Development | 94,267 | 90,969 | 87,323 | 86,444 | 83,944 | 81,372 | 79,524 | 80,861 |
| Sales General & Admin | 285,655 | 278,396 | 259,194 | 265,125 | 245,302 | 241,613 | 238,979 | 242,188 |
| Total Operating Expenses | 391,169 | 387,064 | 374,283 | 365,527 | 340,141 | 334,032 | 329,907 | 334,310 |
| Operating Income (Loss) | 499,810 | 491,660 | 446,537 | 454,540 | 426,268 | 417,243 | 387,312 | 381,218 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1,373) | (5,282) | (3,836) | (979.00) | (4,056) | 2,216 | (2,437) | (2,960) |
| Pretax Income | 502,312 | 496,148 | 446,793 | 458,054 | 417,693 | 418,322 | 383,497 | 357,732 |
| Tax Provision | 103,580 | 103,555 | 98,257 | 78,349 | 52,652 | 73,700 | 72,142 | 65,495 |
| Net Income (Loss) | 398,732 | 392,593 | 348,536 | 379,705 | 365,041 | 344,622 | 311,355 | 292,237 |
| Earnings Per Share (Basic) | 2.74 | 2.69 | 2.38 | 2.59 | 2.49 | 2.35 | 2.12 | 1.99 |
| Earnings Per Share (Diluted) | 2.74 | 2.68 | 2.37 | 2.58 | 2.48 | 2.34 | 2.11 | 1.98 |
| Weighted Average Shares Outstanding (Basic) | 145,340 | 145,842 | 146,182 | 146,716 | 146,719 | 146,810 | 146,861 | 147,021 |
| Weighted Average Shares Outstanding (Diluted) | 145,723 | 146,372 | 146,899 | 147,340 | 147,220 | 147,481 | 147,599 | 147,550 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About RMD
ResMed Inc. (NYSE: RMD) is a stock listed on the New York Stock Exchange under the ticker symbol RMD. It last traded at $235.63 (Nov 20, 2026, 4:00 PM ET), down 0.5% on the day. That gives ResMed a market capitalisation of $33.3B and a price-to-earnings ratio of 20.9.
Over the past 52 weeks RMD has traded between $180.26 and $277.67.
Revenue for the quarter ended Mar 31, 2026 was $1.4B; net income $398.7M. Revenue was up 10.8% from $1.3B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.4B | $398.7M | 27.9% |
| Dec 31, 2025 | $1.4B | $392.6M | 27.6% |
| Sep 30, 2025 | $1.3B | $348.5M | 26.1% |
| Jun 30, 2025 | $1.3B | $379.7M | 28.2% |
From ResMed’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…